HLS THERAPEUTICS INC (HLS.TO) Financials

HLS.TO Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 267.4 million 147.0 million
2023-12-31 277.3 million 147.7 million
2023-09-30 292.5 million 154.2 million
2023-06-30 300.3 million 152.7 million

HLS.TO Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 1.0 million 346177
2023-12-31 4.9 million -797136
2023-09-30 7.2 million -25821
2023-06-30 3.4 million 181361

HLS.TO Net Income

No data available :(

HLS.TO Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 - - 995259
2023-12-31 - - 1.2 million
2023-09-30 29.6 million 116.2 million 1.3 million
2023-06-30 27.7 million 108.0 million 1.3 million

HLS.TO Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 43.1 million
2023-12-31 42.4 million
2023-09-30 43.7 million
2023-06-30 42.8 million

HLS.TO Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 2704 - 9.4 million -
2023-12-31 18568 - 8.0 million -
2023-09-30 237833 - 12.3 million -
2023-06-30 35742 - 12.3 million -

HLS.TO Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 16.9 million 2.4 million
2023-12-31 21.0 million 3.4 million
2023-09-30 21.8 million 2.5 million
2023-06-30 21.7 million 2.4 million

HLS.TO

Price: CA$3.88

52 week price:
3.34
7.12

Forward Dividend Yield: 5.15%

Payout Ratio: -4.31%

Payout Ratio Range:
-666.67%
-4.24%

Dividend Per Share: 0.20 CAD

Earnings Per Share: -1.17 CAD

P/E Ratio: -3.52

Exchange: TOR

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Market Capitalization: 125.3 million

Average Dividend Frequency: 3

Years Paying Dividends: 6

Links: